Option Care Health (NASDAQ:OPCH) Receives “Market Outperform” Rating from JMP Securities

Option Care Health (NASDAQ:OPCH)‘s stock had its “market outperform” rating restated by analysts at JMP Securities in a report issued on Tuesday,Benzinga reports. They currently have a $36.00 price target on the stock. JMP Securities’ target price points to a potential upside of 15.20% from the stock’s current price.

OPCH has been the topic of a number of other reports. Barrington Research restated an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research note on Monday. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, JPMorgan Chase & Co. raised their price target on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $33.75.

Option Care Health Trading Down 2.4 %

Shares of Option Care Health stock opened at $31.25 on Tuesday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The firm has a market cap of $5.13 billion, a price-to-earnings ratio of 26.26, a PEG ratio of 2.30 and a beta of 1.07. Option Care Health has a twelve month low of $21.39 and a twelve month high of $35.53. The business has a 50-day moving average price of $33.32 and a 200-day moving average price of $28.66.

Insider Buying and Selling

In other news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company’s stock, valued at $1,495,835.24. This represents a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.64% of the stock is owned by company insiders.

Institutional Investors Weigh In On Option Care Health

A number of large investors have recently bought and sold shares of the stock. Murphy & Mullick Capital Management Corp purchased a new position in shares of Option Care Health during the fourth quarter valued at approximately $26,000. UMB Bank n.a. boosted its holdings in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after purchasing an additional 346 shares during the last quarter. Signaturefd LLC grew its stake in shares of Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after buying an additional 1,005 shares during the period. Quadrant Capital Group LLC increased its holdings in shares of Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock worth $40,000 after buying an additional 1,099 shares during the last quarter. Finally, Public Employees Retirement System of Ohio raised its holdings in shares of Option Care Health by 21.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock worth $43,000 after purchasing an additional 332 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.